<DOC>
	<DOCNO>NCT01538420</DOCNO>
	<brief_summary>GLPG0492 selective androgen receptor modulator : compound help protect ( help restore ) muscle loss case immobilization ( e.g . orthopedic surgery ) due age ( androgenic effect ) , without anabolic effect ( e.g . effect testosterone ) . In first part current study test whether GLPG0492 give orally healthy male volunteer increase protein synthesis muscle , measure uptake muscle intravenously infused phenylalanine . In second part study , effect compound `` hormone household '' healthy , postmenopausal woman assess .</brief_summary>
	<brief_title>GLPG0492 Pharmacodynamics</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Healthy male , age 1850 year ( part 1 ) , postmenopausal subject age 3565 year ( part 2 ) Body mass index ( BMI ) 1830 kg/mÂ² , inclusive . For men : normal value testosterone ( 175781 ng/dL ) LH ( 1.248.62 U/L ) . Women must postmenopausal least 2 year postmenopausal FSH level accord local lab ( +negative pregnancy test screening &amp; admission ) . smoke drug alcohol abuse hypersensitivity ingredient study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>